Clinical trials with blocked ricin immunotoxins.

作者信息

O'Toole J E, Esseltine D, Lynch T J, Lambert J M, Grossbard M L

机构信息

Hematology-Oncology Unit, Massachusetts General Hospital, Boston 02114, USA.

出版信息

Curr Top Microbiol Immunol. 1998;234:35-56. doi: 10.1007/978-3-642-72153-3_3.

DOI:10.1007/978-3-642-72153-3_3

PMID:9670611

Abstract

摘要

相似文献

Clinical trials with blocked ricin immunotoxins.

Curr Top Microbiol Immunol. 1998;234:35-56. doi: 10.1007/978-3-642-72153-3_3.

Chimeric antigen receptor T-cell immunotherapy tackles blood cancers.

J Natl Cancer Inst. 2015 Apr 2;107(4). doi: 10.1093/jnci/djv112. Print 2015 Apr.

Bispecific, T-Cell-Recruiting Antibodies in B-Cell Malignancies.

Front Immunol. 2020 May 7;11:762. doi: 10.3389/fimmu.2020.00762. eCollection 2020.

Biannual report of the Cochrane Haematological Malignancies Group.

J Natl Cancer Inst. 2004 Aug 4;96(15):E2. doi: 10.1093/jnci/djh242.

Monoclonal antibodies as carriers of toxins.

Prog Clin Biol Res. 1989;288:403-12.

In vitro treatment of bone marrow from patients with T-cell acute lymphoblastic leukemia and non-Hodgkin's lymphoma using the immunotoxin WT1-ricin A.

Haematol Blood Transfus. 1987;31:57-8. doi: 10.1007/978-3-642-72624-8_12.

Clinical Development of PD-1 Blockade in Hematologic Malignancies.

Cancer J. 2018 Jan/Feb;24(1):31-35. doi: 10.1097/PPO.0000000000000297.

The chronic lymphocytic leukemia antigen (cCLLa) as immunotherapy target: pharmacokinetics and biodistribution of two divalent, ricin-based immunotoxins in xenografted athymic mice.

Leuk Lymphoma. 1997 May;25(5-6):509-20. doi: 10.3109/10428199709039039.

Treatment of leukemia patients with T101 ricin A chain immunotoxins.

Cancer Treat Res. 1988;37:483-91. doi: 10.1007/978-1-4613-1083-9_27.

Prospects for immunotoxin therapy of non-Hodgkin's lymphoma.

Clin Immunol Immunopathol. 1995 Aug;76(2):107-14. doi: 10.1006/clin.1995.1103.

引用本文的文献

Antibody-Drug Conjugates for Multiple Myeloma: Just the Beginning, or the Beginning of the End?

Pharmaceuticals (Basel). 2023 Apr 14;16(4):590. doi: 10.3390/ph16040590.

Inclusion of a Furin Cleavage Site Enhances Antitumor Efficacy against Colorectal Cancer Cells of Ribotoxin α-Sarcin- or RNase T1-Based Immunotoxins.

Toxins (Basel). 2019 Oct 12;11(10):593. doi: 10.3390/toxins11100593.

A novel Carcinoembryonic Antigen (CEA)-Targeted Trimeric Immunotoxin shows significantly enhanced Antitumor Activity in Human Colorectal Cancer Xenografts.

Sci Rep. 2019 Aug 12;9(1):11680. doi: 10.1038/s41598-019-48285-z.

Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy.

Curr Pharm Des. 2014;20(42):6584-643. doi: 10.2174/1381612820666140826153913.

A calcium ion-dependent dimeric bean lectin with antiproliferative activity toward human breast cancer MCF-7 cells.

Protein J. 2013 Mar;32(3):208-15. doi: 10.1007/s10930-013-9477-2.

Immunotoxins for targeted cancer therapy.

AAPS J. 2006 Aug 18;8(3):E532-51. doi: 10.1208/aapsj080363.

Identification of ricin A-chain HLA class II-restricted epitopes by human T-cell clones.

Clin Exp Immunol. 2001 Sep;125(3):391-400. doi: 10.1046/j.1365-2249.2001.01525.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验